HUM Humana PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: HUM
- PE Ratio
The PE ratio for Humana stock stands at 17.6 as of May 9, 2025. The calculation is based on the latest EPS of $14.18 and the stock price of $249.53 per share. A decrease of 28% has been observed in the PE ratio compared to its average of 24.5 of the last four quarters.
HUM PE ratio history
Over the last ten years, the average PE ratio of Humana has been 21.31. The current 17.6 P/E ratio is 17% lower than the historical average. Looking back at the last ten years, HUM's PE ratio peaked in the Dec 2016 quarter at 49.64, with a price of $204.03 and an EPS of $4.11. The Sep 2020 quarter marked the lowest point at 13.17, with a price of $413.89 and an EPS of $31.42.
Humana PE ratio by year
Maximum annual increase: 137.51% in 2016
Maximum annual decrease: -70.51% in 2017
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 25.35 | 11.23% | $253.71 | $10.01 |
| 2023 | 22.79 | -1.21% | $457.81 | $20.09 |
| 2022 | 23.07 | 13.37% | $512.19 | $22.2 |
| 2021 | 20.35 | 26.32% | $463.86 | $22.79 |
| 2020 | 16.11 | -11.19% | $410.27 | $25.47 |
| 2019 | 18.14 | -22.51% | $366.52 | $20.2 |
| 2018 | 23.41 | 59.9% | $286.48 | $12.24 |
| 2017 | 14.64 | -70.51% | $248.07 | $16.94 |
| 2016 | 49.64 | 137.51% | $204.03 | $4.11 |
| 2015 | 20.9 | 8.23% | $178.51 | $8.54 |
| 2014 | 19.31 | 46.07% | $143.63 | $7.44 |
| 2013 | 13.22 | 45.59% | $103.22 | $7.81 |
| 2012 | 9.08 | -11.07% | $68.63 | $7.56 |
| 2011 | 10.21 | 22.13% | $87.61 | $8.58 |
| 2010 | 8.36 | 18.25% | $54.74 | $6.55 |
Humana PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | 18.66 | -26.39% | $264.6 | $14.18 |
| Dec 2024 | 25.35 | -8.19% | $253.71 | $10.01 |
| Sep 2024 | 27.61 | 5.06% | $316.74 | $11.47 |
| Jun 2024 | 26.28 | 23.5% | $373.65 | $14.22 |
| Mar 2024 | 21.28 | -6.63% | $346.72 | $16.29 |
| Dec 2023 | 22.79 | 13.72% | $457.81 | $20.09 |
| Sep 2023 | 20.04 | 20.94% | $486.52 | $24.28 |
| Jun 2023 | 16.57 | -15.37% | $447.13 | $26.99 |
| Mar 2023 | 19.58 | -15.13% | $485.46 | $24.79 |
| Dec 2022 | 23.07 | 5.39% | $512.19 | $22.2 |
| Sep 2022 | 21.89 | 15.15% | $485.19 | $22.16 |
| Jun 2022 | 19.01 | 3.48% | $468.07 | $24.62 |
| Mar 2022 | 18.37 | -9.73% | $435.17 | $23.69 |
| Dec 2021 | 20.35 | 9% | $463.86 | $22.79 |
| Sep 2021 | 18.67 | -19.66% | $389.15 | $20.84 |
HUM average PE ratio chart
HUM's current PE ratio is lower than its 3, 5 and 10-year averages.
HUM PE vs peers
HUM's PE ratio stands lower than its peer stock CI, but it is higher than UNH's and CNC's. Humana's current PE ratio of 17.6 is higher than the average of its peers, which is 14.73.
| Stock name | PE ratio | Market cap |
|---|---|---|
| CNC Centene Corp | 9.16 | $30.96B |
| MOH Molina Healthcare Inc | 15.54 | $17.51B |
| UNH Unitedhealth Group Inc | 15.82 | $345.43B |
| CI Cigna Corp | 17.37 | $84.25B |
| HUM Humana Inc | 17.84 | $30.53B |
Frequently asked questions
What is Humana's PE ratio?
HUM's price to earnings ratio is 17.6 as of May 9, 2025.
What is the 3-year average PE ratio for Humana (HUM)?
Over the last 3 years, the average price to earnings ratio for HUM stock is 21.84.
What is the 5-year average PE ratio for Humana (HUM)?
Over the last 5 years, the average price to earnings ratio for HUM stock is 20.08.
What is the highest PE ratio for HUM?
Over the last ten years, the Dec 2016 quarter recorded the highest quarterly PE ratio at 49.64.
How does the current PE ratio for HUM compare to its historical average?
HUM's current price to earnings ratio is 17% below its 10-year historical average.
How is HUM's PE ratio calculated (Humana PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (May 9, 2025), Humana's share price is $249.53. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $14.18. Therefore, Humana's PE ratio for today is 17.6. PE RATIO(17.6) = STOCK PRICE($249.53) / TTM EPS($14.18)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.